Title - Research and Review of EudragitTM Polymers in the Development of pH-Targeted
Pharmaceutical Delivery
Program of Study – Chemistry
Presentation Type – Physical Poster
Subtype –Basic.
Mentor and Mentor Email - Dr. Michael Korn (mrkorn@liberty.edu)
Student Name and Email – Jake Dyess (jadyess@liberty.edu)
Abstract: The following presentation shall be written regarding research performed with Dr.
Korn in his collaboration with Dr. Bauer of Liberty University’s College of Osteopathic
Medicine (LUCOM). The focus of the research is that of polymeric nanoparticles,
specifically a EudragitTM based copolymer in the formation of a capsule for pharmaceutical
payloads. Nanoparticles are particles that possess a dimension that is less than 100nm. They
are being explored for new methods of controlled release systems for treatment to deliver
both soluble and insoluble compounds for medicinal purpose. This research will explore the
properties of nanoparticles constructed from EudragitTM, a copolymer derived of methacrylic
and acrylic esters. One specific goal of the research will be to incorporate an enzyme, such
as alkaline phosphatase, with the nanoparticle. Upon incorporation of the alkaline
phosphatase or a similar biomolecule, experiments will be performed to measure the activity
of the enzyme or biomolecule. The EudragitTM based compound in particular is being
applied as a pharmaceutical delivery system that is pH-selective; it will maintain structure in
acidic environments, but releases the contents in more basic environments. Applied to the
human body, these polymer payloads are designed to carry medication through the acidic
environment of the stomach to the higher pH found within the more basic environment of the
intestines and colonic regions of the body. This research is significant both chemically and

medicinally. Methods of construction of polymeric nanoparticles that generate a microscopic
powder will be researched to increase understanding of the process of generating and
refining polymer capsules. This research may also provide insight in assessing the
EudragitTM nanoparticles’ chemical properties, providing for potential advancement in the
relatively new field of polymeric nanoparticles. Medicinally, the significance is based in
advancing the treatment and care of patients. If certain enzymes, proteins, and medicative
variants may be encapsulated by EudragitTM, treatment options for a variety of illnesses
could increase. Furthermore, treatment may be more effective if implemented into a
polymer, making current treatments or medications more efficacious. The ability to enhance
and create targeted drug delivery systems will expand care and treatment options provided
by physicians to their patients.

